Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms-Reference-Cited by-同舟云学术

Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms

Published:2018-08-10 Issue:11 Volume:19 Page:1318-1326
ISSN:1389-4501
Container-title:Current Drug Targets
language:en
Short-container-title:CDT

Author:

Xu Baohui¹,Xuan Haojun¹,Iida Yasunori¹,Miyata Masaaki²,Dalman Ronald L.¹

Affiliation:

1. Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, California, CA 94305, United States

2. Department of Cardiovascular Medicine and Hypertension, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-0075, Japan

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gasdermin D Inhibitor Necrosulfonamide Alleviates Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice;Biomolecules;2024-06-19

2. Cocktail therapy of combined SGLT2 inhibitor, entresto and adipose-derived mesenchymal stem cells effectively prevents abdominal aortic aneurysmal associated complication syndrome in rodent;2023-07-10

3. Pharmacological Inhibition of Gasdermin D Suppresses Angiotensin II-Induced Experimental Abdominal Aortic Aneurysms;Biomolecules;2023-05-28

4. Risk Factors for Mortality From Aortic Aneurysm and Dissection: Results From a 26‐Year Follow‐Up of a Community‐Based Population;Journal of the American Heart Association;2023-04-18

5. Distinct Mechanisms of β-Arrestin–Biased Agonist and Blocker of AT1R in Preventing Aortic Aneurysm and Associated Mortality;Hypertension;2023-02